
Reset all filters
01 4Bayer Inc.
02 1Gowling Lafleur Henderson LLP
03 9Gowling WLG (Canada) LLP
04 3Gowlings
05 2Ridout & Maybee LLP
Reset all filters
01 31339707
02 31340861
03 11341292
04 21341604
05 12118121
06 12275890
07 12345138
08 12428144
09 12473526
10 52952488
Reset all filters
01 2Interferon Alphacon-1
02 3Interferon beta-1a
03 7Interferon beta-1b
04 7PEGINTERFERON BETA-1A
Reset all filters
01 1KIT
02 6LIQUID
03 1Lyophilized powder for resonstitution
04 4Lyophilized powder with accompanying diluent
05 3Powder for Solution
06 2Solution for Injection
07 2solution
Reset all filters
01 12013-04-14
02 32015-03-10
03 32016-12-28
04 12017-12-23
05 12018-09-18
06 12019-10-15
07 12021-11-07
08 62023-01-17
09 22027-05-04
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Brand Name : BETASERON
Patent Number : 1340861
Filing Date : 1983-10-12
Strength per Unit : 0.3mg per vial (250 ug / mL when reconstituted)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutanous injection
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Brand Name : BETASERON
Patent Number : 1339707
Filing Date : 1986-08-20
Strength per Unit : 0.3mg per vial (250 ug / mL when reconstituted)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutanous injection
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Brand Name : FERONA
Patent Number : 1339707
Filing Date : 1986-08-20
Strength per Unit : 0.3 mg / vial (250 ?g / ml)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Brand Name : FERONA
Patent Number : 1340861
Filing Date : 1983-10-12
Strength per Unit : 0.3 mg / vial (250 ?g / ml)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Brand Name : AVONEX
Patent Number : 1341604
Filing Date : 1981-04-04
Strength per Unit : 30 mcg / 0.5mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Brand Name : AVONEX
Patent Number : 1341604
Filing Date : 1981-04-04
Strength per Unit : 30 mcg / mL
Dosage Form : Lyophilized powder for resonstitution
Human Or VET : Human
Route of Administration : Intramuscular injection
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Brand Name : EXTAVIA
Patent Number : 1340861
Filing Date : 1983-10-12
Strength per Unit : 0.3 mg / vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Brand Name : EXTAVIA
Patent Number : 1339707
Filing Date : 1986-08-20
Strength per Unit : 0.3 mg / vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Patent Expiration Date : 2021-11-07
Date Granted : 2012-01-10
Brand Name : EXTAVIA
Patent Number : 2428144
Filing Date : 2001-11-07
Strength per Unit : 0.3 mg / vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-11-07
Date Granted : 2012-01-10
Patent Expiration Date : 2017-12-23
Date Granted : 2011-11-01
Brand Name : AVONEX
Patent Number : 2275890
Filing Date : 1997-12-23
Strength per Unit : 30 mcg / 0.5mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2017-12-23
Date Granted : 2011-11-01